Editorial

January 27, 2015

Dear ESMINT Friends,

This year, 2015, will prove to be the year in which the results of the positive thrombectomy trials need to be integrated into clinical practice. Therefore, the attention of the regulators, public and our colleagues will be directed to the actions of our specialty and the ESMINT. It has become obvious that the interest in our field from many specialties is growing, but we must be aware that Minimally Invasive Neurological Therapies comprises more than just ischemic stroke treatment. Therefore the annual ESMINT Congress, to be held September 9-12th in Nice, will be focused on the field in its entirety including treatment of both aneurysms and fistulous lesions. We look forward to the participation of colleagues from all over the globe, as was the case in previous meetings.

The growing demand for intra-arterial treatment of ischemic stroke will show us the necessity of proper training. This is something the ESMINT has always sought to establish through the ESMINT-course and -curriculum based on UEMS guidelines. A session during the 7th ESMINT Congress will therefore be dedicated to methods of training, procedure planning and critical assessment (audit). This, in conjunction with a session on complications and ‘bail-out-techniques’ will help the awareness of young colleagues in structuring their entry into this emerging field without ‘clinical experimentation’ and it will also help the trainers to be aware of the value of protocoled training.

The ESMINT-Congress in Nice is well known for encouraging open debate regarding clinical cases and this is not going to change. All clinical sessions will be introduced by a ‘state-of-the-art’ lecture from an invited speaker, followed by two cases from the moderators. Subsequently the submitted ‘case based’ abstracts will be presented and the debate will be enhanced by the moderators.

As it was the case with the previous two editions of our congress, the first day of the meeting is organized in collaboration with the EANS section of Neurovascular Surgery. Both EANS and SLICE will have ESMINT-endorsed meetings that precede the 7th ESMINT Congress, which will guarantee a superb week of exposure to neurovascular pathology and treatment.

We will keep you updated on the program over the course of time and hope to meet with you in Nice.

Patrick A. Brouwer, President of the 7th ESMINT Congress
Laurent Pierot, Vice-president of the 7th ESMINT Congress